Silane-PEG Coated Vial for Rapid PSMA Radiolabeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for radiolabeling prostate-specific membrane antigen (PSMA) ligands with radioactive isotopes like 68Ga, 177Lu, or 90Y are time-consuming, require expensive equipment, and result in significant unbound radioactive isotopes, making them inefficient and costly for both imaging and therapy applications.
Innovation Solution
A 'shake & bake' method involving a reaction vial with a sodium-based buffering agent and PSMA ligand, where a solution of radioactive isotope in HCl is added and incubated, achieving over 90% binding without the need for sophisticated equipment, allowing for rapid and efficient radiolabeling under mild conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional automated synthesis module is used for radiolabeling PSMA tracer, then radiolabeling can be performed with high reliability, but the process is time consuming and requires expensive dedicated machinery occupying large space
Solution Approach 1:
The patent employs disposable reaction vials pre-coated with silane-modified polyethylene glycol, eliminating the need for expensive reusable automated synthesis modules. The disposable nature ensures consistent performance while reducing equipment investment and occupancy space, directly addressing the contradiction between reliability and device complexity
Solution Approach 2:
The reaction vial surface is pre-modified with silane-PEG coating that provides self-assembling properties, allowing the radiolabeling reaction to proceed efficiently without complex external equipment. The coated surface automatically facilitates the reaction between radioactive metal ions and PSMA tracer, reducing dependency on sophisticated machinery
2Stability of the object's composition
If conventional radiolabeling method is used, then radiolabeling can be performed with stable conditions, but unbound radio-isotope requires additional purification step
Solution Approach 1:
The reaction vial surface is pre-coated with silane-modified polyethylene glycol before the radiolabeling reaction. This preliminary surface modification prevents unbound radio-isotope from adhering to the vial walls, thereby eliminating the need for additional purification steps and improving overall productivity while maintaining stable reaction conditions
Solution Approach 2:
The patent converts the potential harmful effect of unbound radio-isotope adhesion into a beneficial feature by using the PEG-coated surface to selectively retain the radiolabeled product while allowing unbound isotope to remain in solution and be easily removed, thus improving efficiency without compromising stability
3Measurement precision
If radiolabeling is performed with short half-life isotope like 68Ga, then imaging quality is improved, but the process must be completed very quickly
Solution Approach 1:
The reaction vials are pre-coated with silane-modified polyethylene glycol and prepared in advance, so that when the short-lived radioactive isotope arrives, the radiolabeling reaction can immediately proceed without time-consuming setup. This preliminary preparation significantly reduces the actual radiolabeling time, enabling effective use of short half-life isotopes like 68Ga for high-quality imaging
Solution Approach 2:
The patent optimizes reaction parameters including temperature, pH, and incubation time specifically for the silane-PEG coated vial system. These parameter optimizations accelerate the radiolabeling kinetics, allowing complete labeling within the short half-life window of isotopes like 68Ga while maintaining high imaging precision
4Ease of operation
If simple reaction vessel is used, then cost is reduced and ease of operation is improved, but binding efficiency decreases
Solution Approach 1:
The patent applies silane-modified polyethylene glycol coating specifically to the inner surface of the reaction vial, creating a localized functional zone that enhances binding efficiency. The bulk reaction vessel remains simple and easy to handle, while the coated surface provides the necessary chemical properties for high-efficiency radiolabeling, thus resolving the contradiction between simplicity and precision
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method simplifies and accelerates the radiolabeling process, reducing equipment needs and unbound isotope removal steps, while maintaining high binding efficiency, making it suitable for both diagnostic and therapeutic applications.
Implementation Method 1
a) A reaction vial surface is coated with a silane-modified polyethylene glycol... b) A solution of a radioactive metal ion in 0.1 N HCl is added to the reaction vial... c) The solution is incubated for 2-5 minutes at 37°C... e) The PSMA tracer is added to the reaction vial and the solution is incubated for 5-10 minutes at 37°C
Implementation Method 2
wherein the radioactive isotope is 68Ga, 177Lu or 90Y... Radiolabeled PSMA ligands prepared by this method can be used for both imaging and therapy purposes
Data Source
AI summary
The present invention relates to a method for labeling a prostate-specific membrane antigen (PSMA) ligand with a radioactive isotope such as 68Ga, 177Lu, or 90Y. Radiolabeled PSMA ligands prepared by this method can be used for both imaging and therapy purposes.